J Korean Med Assoc Search

CLOSE


J Korean Med Assoc > Volume 49(1); 2006 > Article
Whang: Treatment of Acne

Abstract

Acne vulgaris is a self-limited disease, seen primarily in adolescents. Most cases of acne are pleomorphic, presenting various lesions consisting of comedones, pustules, and nodules. Although it has been traditionally classified as a disease of the sebaceous gland, it actually involves the pilosebaceous unit. There are four major principles in the treatment of acne: ① correct the altered pattern of follicular keratinization; ② decrease the sebaceous gland activity; ③ decrease the follicular bacterial population; and ④ produce anti-inflammatory effect. The natural course of acne varies greatly, and therefore, the determination of the therapeutic efficacy of medications for the treatment of acne is far from being simple.

References

2. Irwin MF, Arthur ZE. Fitzpatrick's dermatology 6th ed. New York: Mcgrawhill. 672-688.

3. Del Rosso JQ. Retinoic acid receptors and topical acne therapy. Cutis 2002;70:127-129.

4. Wolf JE. An update of recent clinical trials examining adapalene and acne. J Eur Acad Dermatol Venereol 2001;15:Suppl 3. S23-S29.

5. Kakita L. Tazarotene versus tretinoin or adapalene in the treatment of acne vulgaris. J Am Acad Dermatol 2000;43:S51-S54.

6. Menter A. Pharmacokinetics and safety of tazarotene. J Am Acad Dermatol 2000;43:S31-S35.

7. Millikan LE. Adapalene: an update on newer comparative studies between the various retinoids. Int J Dermatol 2000;39:784-788.

8. Leyden JJ. Current issues in antimicrobial therapy for the treatment of acne. J Eur Acad Dermatol Venereol 2001;15:Suppl 3. S51-S55.

9. Russell JJ. Topical therapy for acne. Am Family Physician 2000;61:357-366.

10. Berson DS, Shalita AR. The treatment of acne: the role of combination therapies. J Am Acad Dermatol 1995;32:S31-S41.

11. Webster G. Combination azelaic acid therapy for acne vulgaris. J Am Acad Dermatol 2000;43:S47-S50.

12. Plewig G, Kligman AM. Acne and rosacea 2000;3rd ed. Berlin: Springer-Verlag. 649-680.

13. Cunliffe WJ, van de Kerkhof PC, Caputo R, Cavicchini S, Cooper A, Shaita A, et al. Roaccutane treatment guidelines: Results of an international survey. Dermatology 1997;194:351-357.

14. Wysowski DK, Swann J, Vega A. Use of isotretinoin (Accutane) in the united states: Rapid increase from 1992 through 2000. J Am Acad Dermatol 2002;46:505-509.

15. Goodman GJ. Management of post-acne scarring. What are the options for treatment? Am J Clin Dermatol 2000;1:3-17.

16. Jacob CI, Dover JS, Kaminer MS. Acne scarring: a classification system and review of treatment options. J Am Acad Dermatol 2001;45:109-117.

17. Sawcer D, Lee HR, Lowe NJ. Lasers and adjunctive treatments for facial scars: a review. J Cutan Laser Ther 1999;1:77-85.

18. Victor ER. Optical treatments for acne. Dermatologic therapy 2005;18:253-266.

Figure 1
Pathophysiology of ance
jkma-49-63-g001-l.jpg
Table 1
Side effects of isotretinoin
jkma-49-63-i001-l.jpg

(modified from ref.12)



ABOUT
ARTICLE CATEGORY

Browse all articles >

ARCHIVES
FOR CONTRIBUTORS
Editorial Office
37 Ichon-ro 46-gil, Yongsan-gu, Seoul
Tel: +82-2-6350-6562    Fax: +82-2-792-5208    E-mail: jkmamaster@gmail.com                

Copyright © 2024 by Korean Medical Association.

Developed in M2PI

Close layer
prev next